Verona Pharma plc (VRNA)
NASDAQ: VRNA · Real-Time Price · USD
106.28
-0.01 (-0.01%)
Sep 18, 2025, 1:22 PM EDT - Market open
Verona Pharma Employees
Verona Pharma had 209 employees as of December 31, 2024. The number of employees increased by 130 or 164.56% compared to the previous year.
Employees
209
Change (1Y)
130
Growth (1Y)
164.56%
Revenue / Employee
$1,060,636
Profits / Employee
-$388,455
Market Cap
9.16B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 209 | 130 | 164.56% |
| Dec 31, 2023 | 79 | 43 | 119.44% |
| Dec 31, 2022 | 36 | 10 | 38.46% |
| Dec 31, 2021 | 26 | -1 | -3.70% |
| Dec 31, 2020 | 27 | -6 | -18.18% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
VRNA News
- 2 days ago - Verona Pharma to Present Additional Analyses of the Phase 3 ENHANCE Studies in COPD at ERS International Congress 2025 - GlobeNewsWire
- 2 months ago - VERONA PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Verona Pharma plc - VRNA - Business Wire
- 2 months ago - Major deals involving U.S. drugmakers and biotechs over the past decade - Reuters
- 2 months ago - Two big reasons why buying Verona was crucial for Merck - Invezz
- 2 months ago - Merck has struck a roughly $10 billion deal to buy Verona Pharma - WSJ
- 2 months ago - Verona Pharma shares jump with Merck set to acquire company in $10 billion deal - Invezz
- 2 months ago - Merck dives into COPD treatments with $10 billion purchase of Verona Pharma - Market Watch
- 2 months ago - Verona Pharma Stock Jumps 21%. It's Being Bought for $10 Billion by Merck. - Barrons